Spine Fusion clinical trials at UCSF

2 research studies open to eligible people

Spine fusion is a way to connect bones in the spine. UCSF is researching how ketamine affects brain signals during surgery. They are also developing a tailored pain relief system for pediatric spine fusion patients.

Showing trials for

  • Ketamine on Intraoperative Motor Evoked Potentials

    open to eligible people ages 18-100

    The goal of this clinical trial is to learn about the effect of ketamine on intraoperative motor evoked potentials in adult patients undergoing thoracolumbar spinal fusions. Participants will undergo a standard anesthetic. In addition to the standard anesthetic, the patients will be administered increasing doses of ketamine with motor-evoked potentials being measured at each dose, to assess any impacts.

    San Francisco, California

  • Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)

    open to eligible people ages 10-21

    The purpose of this collaborative CTSA application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in children undergoing painful surgery.

    San Francisco, California and other locations

Our lead scientists for Spine Fusion research studies include .

Last updated: